NorthWest Biotherapeutics Inc (NWBO)

[MolBiol]

Thanks for the reference. That makes a lot of sense to me since it isn't likely the spread of the cancer to other parts of the body that ultimately takes the life of a GBM patient. It seems a forgone conclusion that PFS is a surrogate endpoint, but probably a very good one. I think there was a post a while back quoting a person from a brain tumor organization/advocacy group? The person quoted had met with the FDA and discussed trial designs and proper endpoints. i beleive it was the view that the bar for approval was pretty low for effectiveness.